Flowjo, LLC
Ashland, OR Bdbi Part of Becton, Dickinson And Co
- UEI
- XE6VSU2W7J71
- CAGE
- 4C403
- Primary NAICS
- 541511 Custom Computer Programming Services
- SAM.gov registration
- Active through
Company facts
- FY2025 rankings
-
Its parent company, Becton, Dickinson and Co, ranks:
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Corporate family
-
-
Parent
Franklin Lakes, NJ
JJFKLGY7TBJ5
-
Parent
Franklin Lakes, NJ
JJFKLGY7TBJ5
- SAM.gov registration date
- Physical address
- 385 Williamson Way, Ashland, OR 97520, USA
- Website
- flowjo.com
- Founded
- 1997
- Employees
- 11-50
- Estimated annual revenue
- $10B+
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $241,395 |
| FY2025 | $132,402 |
| FY2024 | $146,976 |
| FY2023 | $380,106 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Health and Human Services | $241,395 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| De Novo Software LLC | Pasadena, CA | 541511 Custom Computer Programming Services |
| Cytek Biosciences, Inc. | Fremont, CA | 334516 Analytical Laboratory Instrument Manufacturing |
| Sony Corp Of America | — | 334516 Analytical Laboratory Instrument Manufacturing |
| BD Biosciences | Milpitas, CA | 325413 In-Vitro Diagnostic Substance Manufacturing |
| Fluidigm | South San Francisco, CA | 334516 Analytical Laboratory Instrument Manufacturing |
About the company
Flowjo, LLC Bdbi Division, a subsidiary of Becton, Dickinson and Company, sells flow cytometry and single-cell data analysis software to federal research agencies exclusively as a prime contractor through firm fixed-price purchase orders, with no set-aside designations across its recent federal footprint.
Flowjo operates as a 100% prime vendor with no subcontract activity in its federal portfolio. The company delivers software licenses, seat-based portal access, and support services for its proprietary FlowJo platform, a widely used tool for analyzing and visualizing complex biological datasets in genomic and biomedical research. Recent representative contracts include a $282,496.50 web-based site license to the Food and Drug Administration (FDA) with completion through August 1, 2030; a $225,000 software license and support award from the National Institute of Allergy and Infectious Diseases (NIAID) under a Total Small Business set-aside designation; and a $145,525 flow cytometry analysis software purchase order from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) running through January 17, 2027. Most awards carry ceiling values under $50,000, with contract periods typically one to four years.
Customer concentration is steep and aligned with biomedical research. The National Institute of Allergy and Infectious Diseases leads by both award count (18 awards, $2.2 million combined potential value) and dollar share; NIAID's Acquisitions Office alone placed 13 awards worth $776,000. The National Heart Lung and Blood Institute (NHLI) ranks second by volume (22 awards, $301,000 combined potential value) but trails in dollars. The top five customer agencies account for 42% of awards and 77% of combined potential value, nearly all routed through various NIH institutes and centers or the FDA. No Department of Defense, civilian agency IT, or defense contractor teaming relationships appear in the portfolio.
Flowjo's recent activity shows modest contraction. The vendor secured six awards in 2022, six in 2023, five in 2024, three in 2025, and one in 2026 year-to-date, with a combined potential value of $5.6 million across 182 federal awards since 2006. Two awards (combined potential value $306,000) face ultimate completion inside the next twenty-four months, exposing modest recompete opportunity. The portfolio spans 33 distinct customer agencies, but concentration within HHS/NIH represents the overwhelming operating footprint. Flowjo competes full-and-open across all work; the single Total Small Business set-aside award to NIAID is the sole set-aside in the recent dataset.
Flowjo is headquartered in Ashland, Oregon, where all place-of-performance activity is routed. As a Becton Dickinson subsidiary, Flowjo operates within a larger parent-company federal contracting envelope that carries extensive medical device and healthcare IT awards; the source identifies BD as a federal contractor with both prime and subcontract activity across healthcare and defense agencies.
Quick answers
Is Flowjo, LLC registered in SAM.gov?
Yes. Flowjo, LLC's SAM.gov registration is active through December 16, 2026.
How much has Flowjo, LLC received in federal contracts?
Federal contracts obligated $132,402 to Flowjo, LLC in fiscal year 2025 and $900,879 in fiscal years 2023 through 2027.
How does Flowjo, LLC rank among federal contractors?
Flowjo, LLC's parent company, Becton, Dickinson and Co, ranked #15 in PSC 6515 and #27 in PSC 65 in FY2025.
What is Flowjo, LLC's most recent federal award?
Flowjo, LLC's most recent federal contract award is This firm fixed price purchase order is awarded for flowjo licenses to flowjo, LLC. - severable (75N98026P00552), from Office of Logisitics and Acquisition Operations (NIH), on May 20, 2026.
On GovTribe
See Flowjo, LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors